Customer concentration
Approximately 84% of consolidated net sales came from two customers in fiscal 2025, so a loss or slowdown would materially hit revenue and margins.
- Scope
- Life Extension and Herbalife
- Materiality
- high
Integrated Biopharma Inc
Integrated BioPharma, Inc. is a Delaware-based nutraceutical company that manufactures, distributes, markets, and sells vitamins, nutritional supplements, and herbal products. Its business is split between contract manufacturing for branded supplement customers and other business lines that include warehousing, fulfillment, and raw-material distribution.
4,3 %
10,2 %
1,5 %
+8,0 %
4.42
2.21
| % | |
|---|---|
| Contract Manufacturing | 84% Manufactures vitamins and nutritional supplements for third-party brands and distributors. |
| Warehousing and Fulfillment | 6% Provides storage, order fulfillment, and logistics support through MDC Warehousing and Distribution. |
| Raw-Material Distribution | 5% Distributes selected raw materials, including nutritional ingredients, through Chem International. |
| Other Business Lines | 5% Includes inactive subsidiaries and smaller support activities not classified elsewhere. |
The company sells primarily to branded supplement companies, distributors, multilevel marketers, and specialized...
- Branded supplement companiesprimary
Buy contract-manufactured vitamins and supplements for their own distribution channels and brand portfolios.
- Multilevel marketersprimary
Source private-label nutraceutical products manufactured to their specifications for direct selling networks.
- Specialized health-care providerssecondary
Purchase niche nutritional products and herbal formulations for patient or member use.
- Warehousing and fulfillment clientssecondary
Use the company for storage, order processing, and shipping support tied to nutraceutical distribution.
- Raw-material customerssecondary
Buy selected nutritional ingredients and related raw materials through the distribution business.
The company’s customers are located primarily in the United States and Luxembourg, and its business therefore depends...
- •Primary customer demand comes from the United States
- •Luxembourg is a key customer location through Herbalife-related activity
- •Raw materials are sourced from the United States and abroad
- •Transportation delays can affect inbound ingredients and outbound shipments
- •Geographic concentration increases exposure to U.S. consumer demand
Management is focused on retaining its large contract-manufacturing customers while broadening the customer base to...
01
Reduce customer concentrationshort-term
Most revenue comes from two customers, so diversification is critical to stabilize sales and cash flow.
02
Protect manufacturing competitivenessshort-term
Pricing pressure and inflation can compress margins if the company cannot pass through cost increases.
03
Selective operational investmentmedium-term
Machinery, equipment, and fulfillment capacity support service reliability and customer retention.
The company is highly exposed to customer concentration, with most sales tied to two contract-manufacturing clients...
Supply-chain disruption
The company depends on timely receipt of raw materials and transportation capacity, which can be disrupted by geopolitical events, shipping delays, or supplier issues.
- Scope
- Inbound ingredients and outbound shipments
- Materiality
- high
Inflation and pricing pressure
Higher labor, shipping, and supplier costs may not be fully passed through, compressing gross margin.
- Scope
- Manufacturing and logistics costs
- Materiality
- medium
Regulatory compliance
Nutraceutical products are subject to food, supplement, and manufacturing regulations, and non-compliance could lead to enforcement actions or claims.
- Scope
- Product quality and labeling
- Materiality
- medium
Cybersecurity breach
A breach could interrupt systems, expose confidential information, and create remediation and legal costs.
- Scope
- Operational systems and data
- Materiality
- medium
Revenue recognition and sales allowances
Can change reported revenue and gross margin
Inventory valuation
Can create write-downs that reduce gross profit
Long-lived asset impairment
Can lead to non-cash impairment charges
Income taxes and valuation allowances
Can materially affect tax expense and net income
Connect Biopharma Holdings Ltd
CNTB · Pharmaceutical Preparations
Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company focused on developing rademikibart, an antibody designed to target IL-4Rα for asthma and COPD.
Immix Biopharma, Inc.
IMMX · Pharmaceutical Preparations
Xeris Biopharma Holdings, Inc.
XERS · Pharmaceutical Preparations
BioCorRx Inc.
BICX · Services-Specialty Outpatient Facilities, NEC
Inhibitor Therapeutics, Inc.
INTI · Pharmaceutical Preparations
IMMUNIC, INC.
IMUX · Pharmaceutical Preparations
: 28.4.2026